Alvarez & Marsal Adds Senior Healthcare Executive

  Alvarez & Marsal Adds Senior Healthcare Executive

      Steve Geringer Will Lead A&M Healthcare’s Private Equity Services

Business Wire

NEW YORK -- January 22, 2013

Global professional services firm Alvarez & Marsal announced the addition of
Steve Geringer, a senior healthcare executive, advisor and director, to lead
A&M Healthcare Industry Group’s private equity services as a managing director
based in New York.

Mr. Geringer brings significant experience working with organizations focused
on hospital management, outpatient services, managed care, pharmaceutical
benefits, behavioral health and social services, and healthcare information
technology. He also serves as chairman of Amsurg Corp. and a director of Addus
Homecare, Inc., both public corporations; chairman of Qualifacts Systems,
Inc., and a director of Woundcare Specialists, Inc.

“We are excited to have someone with Steve’s qualifications and track record
join us,” said Guy Sansone, head of A&M Healthcare Industry Group. “Private
equity is a growing area of A&M’s healthcare business and Steve is an
important addition to serving the full range of needs of private equity groups
and their healthcare portfolio companies. His C-suite experience and his board
service at private equity sponsored companies add to our appreciation of these
groups’ investment considerations and performance objectives.”

“Steve’s addition underscores our focus on providing an integrated service
offering to the private equity community,” said Michael Cole, healthcare
industry leader of A&M’s Transaction Advisory Group. “The combination of A&M’s
operational advisory capabilities and leading financial and accounting
transaction advisory services has been embraced by healthcare private equity
investors and we continue to invest in the growth of our healthcare private
equity services practice.”

Mr. Geringer’s past roles include serving as: chief executive officer of
Infuscience, Inc. (acquired by Bioscript); chairman and operating partner of
CredenceHealth, Inc. (acquired by Midas+ Solutions, a division of ACS, a unit
of Xerox Corporation); director of CCRx Pharmaceutical Services (acquired by
Omnicare); co-founder and chief executive officer of Clinical Pharmaceuticals
(acquired by PCS Health Systems), and chief executive officer and president of
PCS (later acquired by Eli Lilly & Co).

Mr. Geringer earned a bachelor’s degree in economics from the University of
Pennsylvania. He is immediate past co-chair of Jewish Funders Network, an
international philanthropic organization based in New York; former chairman of
the Jewish Community Foundation of Greater Phoenix, and a past trustee of the
Phoenix Country Day School.

About Alvarez & Marsal: Changing the Business of Healthcare

With nearly three decades of experience providing hands-on support and results
to organizations navigating times of change and challenge, Alvarez & Marsalis
a global professional services firm that specializes in turnaround management,
operational performance improvement and business advisory services. With a
distinctive combination of experienced healthcare industry practitioners and
world-class activist consultants, A&M works with management, boards of
directors and stakeholders of not-for-profit and investor-owned healthcare
providers, biopharmaceutical companies, payors, suppliers and others to
improve operational, financial and clinical performance. A&M professionals
bring a proven execution-oriented approach focused on delivering results
through strategic advisory; financial, operational and clinical performance
improvement; interim, crisis and contract management; turnaround and
restructuring, mergers and acquisitions transaction and financial advisory;
and compliance, governance and investigations.

To learn more about A&M, visit www.alvarezandmarsal.com.

Follow A&M on LinkedIn, Facebook and Twitter.

Contact:

Linden Alschuler & Kaplan, Inc. Public Relations
Hannah Arnold, 212-575-4545
or
Alvarez & Marsal
Rebecca Baker, Chief Marketing Officer, 212-759-4433